-
公开(公告)号：KR1020130078387A
公开(公告)日：2013-07-10
申请号：KR1020110147304
申请日：2011-12-30
Applicant: (주)아모레퍼시픽
CPC classification number: A61K36/82
Abstract: PURPOSE: A composition containing a Camellia sinensis leaf extract, a Camellia sinensis flower extract, and a Camellia sinensis seed extract as active ingredients is provided to activate AMP-activated protein kinase (AMPK), to suppress fatty acid synthesis, and to promote fatty acid oxidation and glucose absorption, thereby preventing and treating metabolic syndrome. CONSTITUTION: A composition for preventing or treating metabolic syndrome contains a Camellia sinensis leaf extract, a Camellia sinensis flower extract, and a Camellia sinensis seed extract as active ingredients, in a weight ratio of 4-12:0.3-4:0.3-4. The composition contains the Camellia sinensis leaf extract and the Camellia sinensis flower and seed extracts in a weight ratio of 4-12:0.2-8. The metabolic syndrome is a glucoside metabolic syndrome or a lipid metabolic syndrome. The metabolic syndrome includes one or more among obesity, hyperlipidemia, type 2 diabetes, arteriosclerosis, myocardial infarction, and angina pectoris. The composition is a pharmaceutical composition. [Reference numerals] (AA) Mixture of Camellia sinensis leaf, flower, and seed extracts; (BB) Camellia sinensis flower extract; (CC) Camellia sinensis seed extract; (DD) Camellia sinensis leaf extract
Abstract translation: 目的：提供含有山茶叶提取物，山茶花提取物和山茶种子提取物作为活性成分的组合物，以激活AMP活化蛋白激酶（AMPK），抑制脂肪酸合成，促进脂肪酸 氧化和葡萄糖吸收，从而预防和治疗代谢综合征。 构成：用于预防或治疗代谢综合征的组合物含有山茶花提取物，山茶花提取物和山茶种子提取物作为活性成分，重量比为4-12:0.3-4:0.3-4。 该组合物含有山茶叶提取物和山茶花和种子提取物，重量比为4-12：0.2-8。 代谢综合征是葡萄糖苷代谢综合征或脂代谢综合征。 代谢综合征包括肥胖，高脂血症，2型糖尿病，动脉硬化，心肌梗塞和心绞痛中的一种或多种。 组合物是药物组合物。 （参考号）（AA）山茶叶，花和种子提取物的混合物; （BB）山茶花提取物; （CC）山茶籽提取物; （DD）山茶叶提取物
-
公开(公告)号：KR1020120136581A
公开(公告)日：2012-12-20
申请号：KR1020110055597
申请日：2011-06-09
Applicant: (주)아모레퍼시픽
Abstract: PURPOSE: A composition containing soybean extract is provided to supply nutrient to epidermal cells of hair root, to prevent hair loss, and to promote hair growth. CONSTITUTION: A composition for preventing hair loss or promoting hair growth contains 0.001-90 wt% of soybean extract as an active ingredient, prepared by extracting 1-70%(v/v) C1-C5 alcohol. A composition for enhancing hair health contains the soybean extract as an active ingredient. The C1-C5 alcohols are methanol, ethanol, isopropyl alcohol, n-propyl alcohol, n-butanol, or isobutanol. The composition is applied to a cosmetic, food, or pharmaceutical composition. [Reference numerals] (AA) Control group; (BB) Embodiment 4; (CC) Embodiment 2
Abstract translation: 目的：提供含有大豆提取物的组合物，以向头发根的表皮细胞提供营养，以防止脱发，并促进头发生长。 构成：通过提取1-70％（v / v）C 1 -C 5醇制备的用于防止脱发或促进毛发生长的组合物含有0.001-90重量％的大豆提取物作为活性成分。 用于增强毛发健康的组合物含有大豆提取物作为活性成分。 C1-C5醇是甲醇，乙醇，异丙醇，正丙醇，正丁醇或异丁醇。 该组合物用于化妆品，食品或药物组合物。 （附图标记）（AA）对照组; （BB）实施例4; （CC）实施例2
-
-
-
公开(公告)号：KR101677254B1
公开(公告)日：2016-11-17
申请号：KR1020150117315
申请日：2015-08-20
Applicant: (주)아모레퍼시픽
Abstract: 본발명은쿠메스트롤; 또는쿠메스트롤을포함하는발아콩추출물을포함하는피부미용용조성물을개시한다.
-
Patent Agency Ranking
公开(公告)号：KR1020150101980A
公开(公告)日：2015-09-04
申请号：KR1020150117315
申请日：2015-08-20
Applicant: (주)아모레퍼시픽
Abstract: 본 발명은 쿠메스트롤; 또는 쿠메스트롤을 포함하는 발아콩 추출물을 포함하는 피부 미용용 조성물을 개시한다.
Abstract translation: 本发明涉及一种用于皮肤护理的化妆品组合物，其包含：香豆素; 或含有香豆素的发芽豆提取物。
-
公开(公告)号：KR1020130044712A
公开(公告)日：2013-05-03
申请号：KR1020110108914
申请日：2011-10-24
Applicant: (주)아모레퍼시픽
Abstract: PURPOSE: A composition containing syringaresinol for treating eye diseases is provided to normalize the function of mitochondria and to prevent or treat eye diseases especially age-related eye diseases. CONSTITUTION: A composition for preventing or treating eye diseases contains 1-80 wt% of syringaresinol. The eye diseases are selected from the group consisting of macular degeneration, uveitis, glaucoma, diabetic retinopathy, and cataract. Syringaresinol is contained in extracts prepared using one or more selected among linseed, Phellodendron amurense Ruprecht, Acanthopanax senticosus, sesame seeds, and ginseng fruits. The composition enhances SIRT 1 expression and mitochondria synthesis. [Reference numerals] (AA) SIRT1 protein expression
Abstract translation: 目的：提供一种含有用于治疗眼睛疾病的丁香ares醇的组合物，用于标准化线粒体的功能，并预防或治疗眼睛疾病，特别是年龄相关的眼睛疾病。 构成：用于预防或治疗眼睛疾病的组合物含有1-80重量％的丁香胺。 眼疾病选自黄斑变性，葡萄膜炎，青光眼，糖尿病性视网膜病变和白内障。 使用一种或多种选自亚麻籽，Phellodendron amurense Ruprecht，Acanthopanax senticosus，芝麻和人参果实中制备的提取物中含有Syringaresinol。 该组合物增强SIRT1表达和线粒体合成。 （AA）SIRT1蛋白表达
-
-
公开(公告)号：KR1020140040790A
公开(公告)日：2014-04-03
申请号：KR1020140028981
申请日：2014-03-12
Applicant: (주)아모레퍼시픽
Abstract: Disclosed is a composition for skin care containing coumestrol or a germinated soy bean extract with coumestrol. The composition for skin care according to an embodiment of the present invention has an excellent skin elasticity improvement effect, a skin wrinkle treatment effect, a skin whitening effect, a skin moisturizing effect, an anti-inflammatory effect, an antibacterial effect, a skin aging control effect, an antioxidative effect, an acne-prone skin treatment effect, a skin irritation reduction effect, a skin constancy maintaining effect, and a skin allergy reduction and treatment effect.
Abstract translation: 公开了一种含有香草酚或具有香豆素的发芽大豆提取物的皮肤护理组合物。 根据本发明的一个实施方式的皮肤护理用组合物具有优异的皮肤弹性改善效果，皮肤皱纹治疗效果，皮肤美白效果，皮肤保湿效果，抗炎作用，抗菌作用，皮肤老化 控制效果，抗氧化作用，痤疮易发皮肤治疗效果，皮肤刺激减轻作用，皮肤持久保持作用，以及皮肤过敏减轻和治疗效果。
-
公开(公告)号：KR1020130064761A
公开(公告)日：2013-06-18
申请号：KR1020130052500
申请日：2013-05-09
Applicant: (주)아모레퍼시픽
IPC: A61K36/258 , A61P25/28 , A61P25/00
CPC classification number: A61K36/258 , A23L19/00 , A23L33/00 , A23L33/10
Abstract: PURPOSE: A composition for activating mitochondria containing a ginseng fruit extract is provided to effectively treat or prevent diseases related to the functional reduction of mitochondria. CONSTITUTION: A composition for activating mitochondria contains a ginseng fruit extract as an effective substance. The composition enhances the muscles. The composition prevents or treats degenerative diseases, brain disorders, neural diseases, heart diseases, liver diseases, kidney diseases, pancreatic diseases, or muscle diseases. The composition activates mitochondria. 10-90 weight% of the effective substance is included in the composition based on the total weight of the composition. [Reference numerals] (AA) Control group; (BB) Positive control group; (CC) Example 1; (DD) Example 2; (EE) Example 3; (FF) Ginsenoside Rg; (GG) Ginsenoside Rb; (HH) Ginsenoside Re
Abstract translation: 目的：提供用于激活含有人参果实提取物的线粒体的组合物，以有效治疗或预防与线粒体功能性降低有关的疾病。 构成：用于激活线粒体的组合物含有人参果实提取物作为有效物质。 组合增强肌肉。 该组合物预防或治疗退行性疾病，脑疾病，神经疾病，心脏病，肝脏疾病，肾脏疾病，胰腺疾病或肌肉疾病。 组合物激活线粒体。 基于组合物的总重量，10-90重量％的有效物质包括在组合物中。 （附图标记）（AA）对照组; （BB）阳性对照组; （CC）实施例1; （DD）实施例2; （EE）实施例3; （FF）人参皂甙Rg; （GG）人参皂甙Rb; （HH）人参皂甙
-
-
-
-
-
-
-
-
-
Search Results
25
records
(took 0.024 seconds)
